Use of magnetic resonance imaging to plan breast conserving surgery following neoadjuvant chemotherapy for early breast cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 658-658 ◽  
Author(s):  
M. Bhattacharyya ◽  
S. Vinnicombe ◽  
D. Ryan ◽  
R. Al-Mufti ◽  
R. Carpenter ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Neoadjuvant Chemotherapy ◽  
Early Breast Cancer ◽  
Breast Conserving Surgery ◽  
Resonance Imaging

Use of magnetic resonance imaging to plan breast conserving surgery following neoadjuvant chemotherapy for early breast cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 658-658
Author(s):  
M. Bhattacharyya ◽  
S. Vinnicombe ◽  
D. Ryan ◽  
R. Al-Mufti ◽  
R. Carpenter ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Neoadjuvant Chemotherapy ◽  
Early Breast Cancer ◽  
Breast Conserving Surgery ◽  
Resonance Imaging

Breast-conserving surgery using supine magnetic resonance imaging in breast cancer patients receiving neoadjuvant chemotherapy

The Breast ◽  
2008 ◽  
Vol 17 (3) ◽  
pp. 245-251 ◽  
Author(s):  
Rikiya Nakamura ◽  
Takeshi Nagashima ◽  
Masahiro Sakakibara ◽  
Takafumi Sangai ◽  
Hiroshi Fujimoto ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Breast Conserving Surgery ◽  
Breast Cancer Patients ◽  
Resonance Imaging

scholarly journals Contrast-enhanced spectral mammography in the radiological assessment of response to neoadjuvant chemotherapy in breast cancer

2021 ◽  
pp. e521
Author(s):  
Anna Grażyńska ◽  
Sofija Antoniuk ◽  
Katarzyna Steinhof-Radwańska
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Neoadjuvant Chemotherapy ◽  
Residual Disease ◽  
Tumour Size ◽  
Breast Cancer Diagnosis ◽  
Chemotherapy Response ◽  
Resonance Imaging ◽  
Contrast Enhanced

Accurate morphological assessment and measurement of the residual disease following neoadjuvant chemotherapy are vital for the effective surgical treatment in patients with breast cancer. Neoadjuvant chemotherapy response is measured by RECIST 1.1 criteria (Response Evaluation Criteria in Solid Tumors), and the classification of the specific therapeutic responses is based on the difference in the tumour size prior to and after chemotherapy. There are currently a few methods of imaging used in the assessment of the neoadjuvant chemotherapy response. Conventional mammography remains the most popular method, whereas magnetic resonance imaging is considered the most effective ones. Nonetheless, the available methods tend to be imperfect and limited, and therefore, new methods are constantly investigated. Contrast-enhanced spectral mammography is a relatively new method used in breast cancer diagnosis, which involves the phenomenon of neoangiogenesis of cancerous tumours, allowing contrast enhancement in the areas of vessel proliferation in the background of the surrounding breast tissue. Contrast-enhanced spectral mammography presents sensitivity similar to magnetic resonance imaging in breast cancer detection, and can be an efficient method used in monitoring neoadjuvant chemotherapy response.

Sign in / Sign up

Export Citation Format

Share Document